During Stably Suppressive Antiretroviral Therapy Integrated HIV-1 DNA Load in Peripheral Blood is Associated with the Frequency of CD8 Cells Expressing HLA-DR/DP/DQ

EBioMedicine

Volumn 2, Issue 9, 2015, Pages 1153-1159

  Ruggiero, Alessandra ^a   De Spiegelaere, Ward ^b   Cozzi Lepri, Alessandro ^c   Kiselinova, Maja ^b   Pollakis, Georgios ^a   Beloukas, Apostolos ^a   Vandekerckhove, Linos ^b   Strain, Matthew ^d   Richman, Douglas ^d   Phillips, Andrew ^c   Geretti, Anna Maria ^a   Vitiello, Paola ^e   Mackie, Nicola ^f   Ainsworth, Jonathan ^g   Waters, Anele ^g   Post, Frank ^h   Edwards, Simon ⁱ   Fox, Julie ^j  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

^g NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^h KING S COLLEGE HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^j ST THOMAS HOSPITAL   (United Kingdom)

more..

Author keywords

Activation; Integration; Persistence; Reservoir; Suppression

Indexed keywords

CD14 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; EFAVIRENZ; HLA DQ ANTIGEN; NEVIRAPINE; HLA DP ANTIGEN; HLA DR ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; LONG TERMINAL REPEAT; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LOAD; BLOOD; CD8+ T LYMPHOCYTE; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD8-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; FEMALE; HIV-1; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; VIRAL LOAD;

EID: 84953743886     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2015.07.025     Document Type: Article

References (30)

1. Arruvito L., Payaslian F., Baz P., Podhorzer A., Billordo A., Pandolfi J., et al. Identification and clinical relevance of naturally occurring human CD8+HLA-DR+ regulatory T cells. J. Immunol. 2014, 193:4469-4476.
2. Besson G.J., Lalama C.M., Bosch R.J., Gandhi R.T., Bedison M.A., Aga E., et al. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy. Clin. Infect. Dis. 2014, 59:1312-1321.
3. Buzon M.J., Massanella M., Llibre J.M., Esteve A., Dahl V., Puertas M.C., et al. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nat. Med. 2010, 16:460-465.
4. Chomont N., El-Far M., Ancuta P., Trautmann L., Procopio F.A., Yassine-Diab B., et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 2009, 15:893-900.
5. Chun T.W., Murray D., Justement J.S., Hallahan C.W., Moir S., Kovacs C., et al. Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy. J. Infect. Dis. 2011, 204:135-138.
6. Cockerham L.R., Siliciano J.D., Sinclair E., O'Doherty U., Palmer S., Yukl S.A., et al. CD4+ and CD8+ T cell activation are associated with HIV DNA in resting CD4+ T cells. PLoS One 2014, 9:e110731.
7. De Spiegelaere W., Malatinkova E., Lynch L., Van Nieuwerburgh F., Messiaen P., O'Doherty U., et al. Quantification of integrated HIV DNA by repetitive-sampling Alu-HIV PCR on the basis of Poisson statistics. Clin. Chem. 2014, 60:886-895.
8. Doyle T., Smith C., Vitiello P., Cambiano V., Johnson M., Owen A., et al. Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin. Infect. Dis. 2012, 54:724-732.
9. Fletcher C.V., Staskus K., Wietgrefe S.W., Rothenberger M., Reilly C., Chipman J.G., et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:2307-2312.
10. Geretti A.M., Arribas J.R., Lathouwers E., Foster G.M., Yakoob R., Kinloch S., et al. Dynamics of cellular HIV-1 DNA levels over 144weeks of darunavir/ritonavir monotherapy versus triple therapy in the MONET trial. HIV Clin. Trials 2013, 14:45-50.
11. Geretti A.M., Conibear T., Hill A., Johnson J.A., Tambuyzer L., Thys K., Vingerhoets J., Van Delft Y., SENSE Study Group Sensitive testing of plasma HIV-1 RNA and Sanger sequencing of cellular HIV-1 DNA for the detection of drug resistance prior to starting first-line antiretroviral therapy with etravirine or efavirenz. J. Antimicrob. Chemother. 2014, 69:1090-1097.
12. Gianella S., Massanella M., Richman D.D., Little S.J., Spina C.A., Vargas M.V., et al. Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment. J. Virol. 2014, 88:7818-7827.
13. Graf E.H., O'Doherty U. Quantitation of integrated proviral DNA in viral reservoirs. Curr. Opin. HIV AIDS 2013, 8:100-105.
14. Hatano H., Jain V., Hunt P.W., Lee T.H., Sinclair E., Do T.D., et al. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J. Infect. Dis. 2013, 208:50-56.
15. Hunt P.W., Sinclair E., Rodriguez B., Shive C., Clagett B., Funderburg N., et al. Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J. Infect. Dis. 2014, 210:1228-1238.
16. Josefsson L., von Stockenstrom S., Faria N.R., Sinclair E., Bacchetti P., Killian M., et al. The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:E4987-E4996.
17. Klatt N.R., Chomont N., Douek D.C., Deeks S.G. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol. Rev. 2013, 254:326-342.
18. Maldarelli F., Wu X., Su L., Simonetti F.R., Shao W., Hill S., et al. HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 2014, 345:179-183.
19. Marchetti G., Cozzi-Lepri A., Merlini E., Bellistri G.M., Castagna A., Galli M., et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS 2011, 25:1385-1394.
20. Palmer S., Maldarelli F., Wiegand A., Bernstein B., Hanna G.J., Brun S.C., et al. Low-level viremia persists for at least 7years in patients on suppressive antiretroviral therapy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:3879-3884.
21. Ruelas D.S., Greene W.C. An integrated overview of HIV-1 latency. Cell 2013, 155:519-529.
22. Saez-Cirion A., Lacabaratz C., Lambotte O., Versmisse P., Urrutia A., Boufassa F., et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6776-6781.
23. Sandler N.G., Wand H., Roque A., Law M., Nason M.C., Nixon D.E., et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J. Infect. Dis. 2011, 203:780-790.
24. Shan L., Siliciano R.F. Unraveling the relationship between microbial translocation and systemic immune activation in HIV infection. J. Clin. Invest. 2014, 124:2368-2371.
25. Siliciano J.D., Kajdas J., Finzi D., Quinn T.C., Chadwick K., Margolick J.B., et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 2003, 9:727-728.
26. Soriano-Sarabia N., Bateson R.E., Dahl N.P., Crooks A.M., Kuruc J.D., Margolis D.M., et al. Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells. J. Virol. 2014, 88:14070-14077.
27. Strain M.C., Lada S.M., Luong T., Rought S.E., Gianella S., Terry V.H., et al. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One 2013, 8:e55943.
28. von Stockenstrom S., Odevall L., Lee E., Sinclair E., Bacchetti P., Killian M., et al. Longitudinal genetic characterization reveals that cell proliferation maintains a persistent HIV type 1 DNA pool during effective HIV therapy. J. Infect. Dis. 2015, 212:96-607. 10.1093/infdis/jiv092.
29. Wagner T.A., McLaughlin S., Garg K., Cheung C.Y., Larsen B.B., Styrchak S., et al. HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science 2014, 345:570-573.
30. Zubkova I., Duan H., Wells F., Mostowski H., Chang E., Pirollo K., et al. Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees. Hepatology 2014, 59:803-813.